| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.083 | 0.008 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.01 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.01 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.01 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.13 | 0.01 |